Drug Patent Expirations in October 2010

Drug Patent Expirations in October 2010

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent Number Patent Expiration
ORGARANOrganon Usa Incdanaparoid sodium5,164,377Oct 3, 2010
MIRAPEX ERBoehringer Ingelheimpramipexole dihydrochloride4,886,812Oct 8, 2010
MIRAPEXBoehringer Ingelheimpramipexole dihydrochloride4,886,812Oct 8, 2010
CLIMARA PROBayer Hlthcareestradiol; levonorgestrel5,770,219Oct 12, 2010
CLIMARA PROBayer Hlthcareestradiol; levonorgestrel5,252,334Oct 12, 2010
MENTAXMylanbutenafine hydrochloride5,021,458Oct 18, 2010
NUVIGILCephalonarmodafinil4,927,855*PEDOct 22, 2010
CETROTIDEEmd Seronocetrorelix5,198,533Oct 24, 2010
TRITECGlaxosmithklineranitidine bismuth citrate5,256,684Oct 26, 2010
INVEGA SUSTENNAJohnson And Johnsonpaliperidone palmitate5,254,556Oct 27, 2010
COMTANOrionentacapone5,135,950Oct 31, 2010
STALEVO 125Orioncarbidopa; entacapone; levodopa5,135,950Oct 31, 2010
STALEVO 200Orioncarbidopa; entacapone; levodopa5,135,950Oct 31, 2010
STALEVO 75Orioncarbidopa; entacapone; levodopa5,135,950Oct 31, 2010
STALEVO 100Orioncarbidopa; entacapone; levodopa5,135,950Oct 31, 2010
STALEVO 150Orioncarbidopa; entacapone; levodopa5,135,950Oct 31, 2010
STALEVO 50Orioncarbidopa; entacapone; levodopa5,135,950Oct 31, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


   No Comments yet


  1. patent litigation
      November 1, 2010

    Yes, the “patent cliff” is fast upon us. What with so many biotech and similar companies now starting to face the dreaded moment, now is the time to start diversifying and shoring up their assets, if they haven’t done so already.
    http://www.generalpatent.com/media/videos/patent-suits

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: